| English Name | Research Code | Highest Development Stage | Company | Indication | Clinical Trial |
|---|---|---|---|---|---|
| PRAX-562 | PRAX-562 | Phase 3 Clinical | Praxis Precision Medicines | Brain Diseases; Epilepsy | Details |
| XEN-901 | NBI-921352; XEN-901 | Phase 2 Clinical | Xenon Pharma | Epilepsies, Partial; Brain Diseases; Epilepsy | Details |
| PRAX-330 | GS-458967; GS-967; PRAX-330 | Phase 1 Clinical | Praxis Precision Medicines Inc | Epilepsy | Details |
| NBI-355 | NBI-355 | Phase 1 Clinical | Neurocrine Biosciences Inc | Epilepsy | Details |
| English Name | Research Code | Highest Development Stage | Company | First Brand Name | First Approved Country | First Indication | First Approved Company | First Approved Date | Indication | Clinical Trial |
|---|---|---|---|---|---|---|---|---|---|---|
| Pirmenol Hydrochloride | CI-845 | Approved | Sumitomo Dainippon, Pfizer Inc | Pimavar, Pimenol | Japan | Arrhythmias, Cardiac | null | 1994-01-01 | Arrhythmias, Cardiac | Details |